Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Type 2 Diabetes Mellitus.”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT06649344
What this trial is testing

HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin Monotherapy or in Combination With SGLT2 Inhibitors in Participants With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Fujian Shengdi Pharmaceutical Co., Ltd. 884
Testing effectiveness (Phase 2)WithdrawnNCT04662164
What this trial is testing

Access the Efficacy in Type 2 Diabetes Mellitus on Stable Metformin

Who this might be right for
Type 2 Diabetes Patients
Shanghai HEP Pharmaceutical Co., Ltd.
Large-scale testing (Phase 3)Study completedNCT02607306
What this trial is testing

A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 819
Testing effectiveness (Phase 2)Study completedNCT02324309
What this trial is testing

BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500 Post-Meal Glucose Control in Patients With Severe Insulin Resistance

Who this might be right for
Diabetes Mellitus
Biodel 12
Testing effectiveness (Phase 2)Study completedNCT01619332
What this trial is testing

Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763

Who this might be right for
Type II Diabetes
Novartis Pharmaceuticals 220
Early research (Phase 1)Study completedNCT00642798
What this trial is testing

An Open-Label, Single- & Multiple-Dose Study to Investigate the Pharmacokinetics of Sitagliptin 100 mg in Healthy Chinese Adult Subjects (0431-108)(COMPLETED)

Who this might be right for
Diabetes Mellitus Non-insulin-dependent
Merck Sharp & Dohme LLC 16
Post-approval studies (Phase 4)Study completedNCT03202563
What this trial is testing

Trial to Evaluate the Efficacy on Glycemic Variability and Safety of Gemigliptin Compared With Dapagliflozin Added on Metformin Alone or Diabetes Medication Naïve Patient in Type 2 Diabetes Mellitus (Stable II Study)

Who this might be right for
Type 2 Diabetes Mellitus
LG Chem 71
Testing effectiveness (Phase 2)Study completedNCT02434744
What this trial is testing

Study of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Response Pharmaceuticals 121
Large-scale testing (Phase 3)Study completedNCT00097500
What this trial is testing

Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 69
Testing effectiveness (Phase 2)Study completedNCT00770640
What this trial is testing

Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure.

Who this might be right for
Diabetes Mellitus
Takeda 40
Large-scale testing (Phase 3)Study completedNCT00286455
What this trial is testing

Efficacy and Safety of Alogliptin in Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus
Takeda 329
Testing effectiveness (Phase 2)Study completedNCT01399580
What this trial is testing

A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy

Who this might be right for
Chronic Kidney DiseaseDiabetic Nephropathy
AbbVie (prior sponsor, Abbott) 48
Early research (Phase 1)Study completedNCT01469468
What this trial is testing

Estimate The Effect Of Repeated Dosing of PF-05175157 On The Pharmacokinetics Of A Single Dose Of Simvastatin In Healthy Adult Subjects

Who this might be right for
Type 2 Diabetes Mellitus
Pfizer 14
Early research (Phase 1)Study completedNCT03288740
What this trial is testing

A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese Subjects

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 36
Large-scale testing (Phase 3)Study completedNCT00560417
What this trial is testing

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 339
Testing effectiveness (Phase 2)Study completedNCT02081118
What this trial is testing

Glycaemic Control of Monthly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Hanmi Pharmaceutical Company Limited 209
Testing effectiveness (Phase 2)Study completedNCT00451620
What this trial is testing

Effect of GlucoNorm vs Glyburide on Post-Prandial Hyperglycemia in Elderly Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
University of British Columbia 30
Early research (Phase 1)Study completedNCT01274663
What this trial is testing

PF-05175157 In Healthy Volunteers

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 63
Large-scale testing (Phase 3)Study completedNCT00327015
What this trial is testing

BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

Who this might be right for
Diabetes
AstraZeneca 1,306
Early research (Phase 1)Study completedNCT00376038
What this trial is testing

Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusDiabetes Mellitus, Type 2
GlaxoSmithKline 13
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation